
无数据
无数据
无数据
| CAS Number | 557795-19-4 |
| Catalog Number | AG0035WO |
| Chemical Name | SU-11248 |
| IUPAC Name | N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| InChI | InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12- |
| InChI Key | WINHZLLDWRZWRT-ATVHPVEESA-N |
| MDL Number | MFCD09260778 |
| Molecular Formula | C22H27FN4O2 |
| Molecular Weight | 398.4738 |
| NSC Number | 750690 |
| SMILES | C(C)N(CCNC(=O)C1=C(NC(=C1C)C=C1/C(NC2=CC=C(C=C12)F)=O)C)CC |
| UNII | V99T50803M |
| Synonyms | 5-(5-fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide,
SU 011248,
SU 11248,
SU-011248,
SU-11248,
SU011248,
SU11248,
sunitinib,
sunitinib malate,
Sutent,
Sunitinib,
557795-19-4,
Sutent,
Sunitinib malate,
SU11248,
sunitinibum,
Sunitinib Base,
SU-11248,
Su-011248,
SU 11248,
UNII-V99T50803M,
342641-94-5,
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide,
CHEMBL535,
N-[2-(diethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide,
CHEBI:38940,
NSC750690,
V99T50803M,
(Z)-N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide,
341031-54-7,
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide,
MFCD09260778,
5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE,
N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide,
Sunitinib (INN),
1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-,
Sunitinib (free base),
Sunitinib [INN:BAN],
C22H27FN4O2,
HSDB 7932,
(Z)-Sunitinib,
1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-,
5-(5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide,
5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide,
n-(2-(diethylamino)ethyl)-5-((z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-carboxamide,
n-[2-(diethylamino)ethyl]-5-[(z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide,
Sutent (free base),
yrrole-3-carboxamide,
KS-5022,
AC1NS62J,
SCHEMBL8081,
BDBM4814,
GTPL5713,
QCR-67,
Sutent, Sunitinib, SU11248,
CHEBI:91430,
EX-A553,
WINHZLLDWRZWRT-ATVHPVEESA-N,
BCPP000057,
K00588a,
5-(5-Fluoro-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid (2-diethylaminoethyl)amide,
AOB87111,
ZINC3964325,
CF-876,
HY-10255A,
s7781,
AKOS015908193,
AKOS025312424,
AN-9681,
API0024677,
CS-1670,
DB01268,
NSC-750690,
NCGC00164631-02,
NCGC00164631-04,
AJ-47545,
EN002687,
N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide,
Q572,
SC-47294,
AB0017673,
AX8033294,
LS-187023,
LS-187648,
ST2413814,
AM20090630,
FT-0083556,
95S194,
D08552,
J90060,
W-2596,
AB01273976-01,
AB01273976-02,
AB01273976_04,
SR-00000000005,
I01-1229,
SR-00000000005-2,
ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide,
Z2568722545,
N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-,
1H-Pyrrole-3-carboxamide,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-,
(Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-p,
5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid(2-diethylamino-ethyl)-amide,
N-[2-(Diethylamino)ethyl]-5-(2-oxo-5-fluoroindoline-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide,
N-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide,
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide,
N-[5-(Trifluoromethyl)-2-pyridinyl]-trans-4-[[(1,1-dimethylethyl)sulfonyl]amino]cyclohexane-1-carboxamide,
Sunitanib,
Sunitinib [INN],
PDGF TK antagonist,
Sutent (TN),
Sunitinib, Free base,
Sunitinib malate [USAN],
D0R0MW,
UNII-LVX8N1UT73,
cc-689,
SU011248 L-malate salt,
Sunitinib (Pan-TK inhibitor),
PHA-290940AD,
C22-H27-F-N4-O2,
SU-11248J,
SU011248,
ACN-036767,
CID5329102,
CS-O-11750,
SU 011248,
NCGC00164631-01,
SU-12662,
SU010398,
SU-010398,
2035B,
C22-H27-F-N4-O2.C4-H6-O5,
C473478,
D000077210,
341031-54-7 (malate); 557795-19-4 (free base).,
5-(5-fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide,
B49,
|
| Complexity | 636 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Exact Mass | 398.212g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 29 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 3 |
| Isotope Atom Count | 0 |
| Molecular Weight | 398.482g/mol |
| Monoisotopic Mass | 398.212g/mol |
| Rotatable Bond Count | 7 |
| Topological Polar Surface Area | 77.2A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.6 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H332-H335 |
| Packing Group | |
| Precautionary statements | P280-P305+P351+P338-P310 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

